The RWD & RWE Podcast

Ep 170 [02 April 2025]: Christian Nguyen PharmD MS MBA – RWE & Me: Lessons from a Pharma Leader’s Journey

Ep 170 [02 April 2025]: Name, Christian Nguyen PharmD MS MBA—a visionary leader in real-world evidence and former SVP of Value Evidence & Outcomes at Lilly – We dove into the evolution of real-world data (RWD) into real-world evidence (RWE) and what it means for the future of drug development, market access, and patient care. Christian also shared firsthand experiences from the front lines of RWE generation, lessons learned, and the biggest gaps that still need to be addressed. Beyond the science, we explored career-defining moments and the business trends shaping the industry—how data-driven decision-making is transforming pharma and what professionals need to do to stay ahead.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 169 [19 March 2025]: Prof. Siegal Sadetzki MD MPH M.Sc. – Real-World Data: The 21st Century Take on Epidemiology

Ep 169 [19 March 2025]: Prof. Siegal Sadetzki MD MPH M.Sc., leading public health practitioner & epidemiologist, and Chief Epidemiology Officer at Briya – We learned why Prof. Sadetzki believes RWD is the 21st-century take on modern epidemiology, merging traditional epi approaches with innovative big data methods. We discussed the advantages of digitalized, comprehensive real-world data and how it enhances population representation, full patient-journey tracking, and unlocks deeper scientific insights, optimizing clinical decision-making.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 168 [12 March 2025]: Jean van Soelen – We are SEER-ious about our oncology Real-World Data!

Ep 168 [12 March 2025]: Jean van Soelen, Founder and CEO of saleSEER, a data intelligence company specializing in Oncology – We discussed her nearly 14 years on the supply side of RWD has entailed and share her insights on optimizing data consumer <> supplier business engagements and thoughts about the future of RWD for a variety of life science use cases.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 167 [05 March 2025]: Mike D'Ambrosio – CROwing about RWE: The study. The goal. The CRO.

Ep 167 [05 March 2025]: Mike D'Ambrosio, SVP - Global Head Real World Research at Parexel – We explored his career journey and the experiences that have shaped his perspective on successful RWE studies and long-term evidence generation.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 166 [26 February 2025]: Mika Newton – Into Interoperability: The Internet of Healthcare RWD

Ep 166 [26 February 2025]: Mika Newton, CEO of xCures – We discussed: What is interoperability? Who are the players? How do we accessing these networks? What are treatment relationships vs. Individual Access Services? Plus we'll focus on use cases for RWD.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club.Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 165 [19 February 2025]: Justin Spencer – Unlocking Healthcare Data: Research Partnerships That Work

Ep 165 [19 February 2025]: Justin Spencer, CEO at Azimuth Research Group – We discussed how to unlock healthcare data through research partnerships that work: partnering with health systems provides access to rich, fit-for-purpose data that empowers retrospective and prospective research, driving better outcomes and innovation in precision medicine.Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.clubDisclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 164 [12 February 2025]: Mayowa Oyesanya MD – Mind the Mind: The importance of Behavioral Health RWD

Ep 164 [12 February 2025]: Mayowa Oyesanya MD, Medical Director at Holmusk and practising NHS psychiatrist in the UK – We discussed how to maximise the potential of real-world data in neuropsychiatry by; leveraging different types of data, applying newer methods, and carefully considering use cases for RWD.Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 163 [29 January 2025]: Jack DiGiovanna PhD – A bridge to somewhere: Genomics with RWD

Ep 163 [29 January 2025]: Jack DiGiovanna PhD, the CSO of Velsera, which resulted from the merger of Seven Bridges, Pierian and UgenTec back in January 2023. – We discussed that the merged firms continue building across digital diagnostics, bio­informatics, healthcare data and advanced analytics to enable better healthcare, diagnostics, and precision medicine research. Velsera is working across the spectrum, from unique data generation, to data assembly and data access, generating substantial impact in the market.Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 162 [22 January 2025]: Chuka Esiobu – Investor's perspective: Investing in the RWD/RWE sector

Ep 162 [22 January 2025]: Chuka Esiobu, Principal at Define Ventures – We discussed the investor's perspective of the RWD/RWE sectors and key considerations for both investors -- and those raising capital -- in this dynamic and rapidly evolving arena.Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 161 [15 January 2025]: Len Rosenberg, PhD – “Real World Stuff” the Oxymoronic State of Clinical Research

Ep 161 [15 January 2025]: Len Rosenberg, PhD, Head, Clinical Operations at Beat AML, LLC, a division of The Leukemia & Lymphoma Society and Managing Partner of eP2Consulting, Inc. – Len is the co-founder of several companies in the biotech & clinical services/CRO sector and a board memberat multiple companies including non-profits, sharing several decades of experience in the life science arena.Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.